ArticleJAMA network open2023

Use of Expedited Regulatory Programs and Clinical Development Times for FDA-Approved Novel Therapeutics.

Alissa K Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.